NextPlat (NXPL) Net Shares Issued and Repurchased (2015 - 2020)
NextPlat's (NXPL) quarterly Net Shares Issued and Repurchased came in at $3.5 million in Q4 2020, up 69740.0% year-over-year from N/an in Q1 2020, and up 69740.0% quarter-over-quarter from $5000.0 in Q4 2019.
Analysis
NextPlat (NXPL) Net Shares Issued and Repurchased (2015 - 2020) Analysis & Trends
NextPlat (NXPL) has reported Net Shares Issued and Repurchased for 6 consecutive years, with $3.5 million the latest figure, recorded in Q4 2020.
- On a quarterly basis, Net Shares Issued and Repurchased rose 69740.0% year-over-year to $3.5 million in Q4 2020; TTM through Dec 2020 was $3.5 million, a 69740.0% increase from a year earlier, with the FY2020 full-year figure at $3.5 million, up 69740.0% from the prior year.
- Net Shares Issued and Repurchased was $3.5 million for Q4 2020 at NextPlat, up from $5000.0 in the prior quarter.
- Over five years, Net Shares Issued and Repurchased peaked at $3.5 million in Q4 2020 and troughed at $5000.0 in Q4 2019.
- A 5-year average of $767483.4 and a median of $73750.0 in 2018 frame the typical range for Net Shares Issued and Repurchased.
- Across the five-year window, Net Shares Issued and Repurchased plunged 93.22% in 2019 and jumped 69740.0% in 2020, its largest moves.
- Over 5 years, Net Shares Issued and Repurchased stood at $66667.0 in 2016, then jumped by 200.0% to $200000.0 in 2017, then tumbled by 63.12% to $73750.0 in 2018, then sank by 93.22% to $5000.0 in 2019, then jumped by 69740.0% to $3.5 million in 2020.
- The last three Net Shares Issued and Repurchased figures came in at $3.5 million (Q4 2020), $5000.0 (Q4 2019), and $73750.0 (Q4 2018), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | - |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | - |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | - |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 31,000.00 |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 3.49 Mn |
| Dec 31, 2019 | 5,000.00 |
| Dec 31, 2018 | 73,750.00 |
| Dec 31, 2017 | 200,000.00 |
| Dec 31, 2016 | 66,667.00 |
| Dec 31, 2015 | 700,000.00 |